Successful management of chronic eosinophilic pneumonia triggered by immune checkpoint inhibitor: a case report and literature review
Immune checkpoint inhibitors (ICIs) enhance antitumor immunity by blocking inhibitory immune signals, but can lead to immune-related adverse events (irAEs). Therefore, effective management of irAEs is crucial during ICI therapy. We report the case of a…